Literature DB >> 7137736

Human brucellosis caused by Brucella canis: clinical features and immune response.

S S Polt, W E Dismukes, A Flint, J Schaefer.   

Abstract

Human infection by Brucella canis is not often recognized due to a lack of serious consideration of the disease as a diagnostic possibility. Another factor is the limited availability of specific serologic tests needed in the absence of cross-reactivity between antibodies to B. canis and other Brucella pathogenic to humans. In addition, the organism may not be isolated from blood culture, particularly after antibiotic therapy. We report clinical and laboratory features of four patients with serologically diagnosed B. canis infection and point out the importance of specific serologic testing for B. canis when brucellosis is a diagnostic possibility.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7137736     DOI: 10.7326/0003-4819-97-5-717

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

1.  Enzyme-linked immunosorbent assay with major outer membrane proteins of Brucella melitensis to measure immune response to Brucella species.

Authors:  S B Hunter; W F Bibb; C N Shih; A F Kaufmann; J R Mitchell; R M McKinney
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

2.  Determination by enzyme-linked immunosorbent assay of immunoglobulin G (IgG), IgM, and IgA to Brucella melitensis major outer membrane proteins and whole-cell heat-killed antigens in sera of patients with brucellosis.

Authors:  G F Araj; A F Kaufmann
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

3.  Brucella canis is an intracellular pathogen that induces a lower proinflammatory response than smooth zoonotic counterparts.

Authors:  Carlos Chacón-Díaz; Pamela Altamirano-Silva; Gabriela González-Espinoza; María-Concepción Medina; Alejandro Alfaro-Alarcón; Laura Bouza-Mora; César Jiménez-Rojas; Melissa Wong; Elías Barquero-Calvo; Norman Rojas; Caterina Guzmán-Verri; Edgardo Moreno; Esteban Chaves-Olarte
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

Review 4.  Laboratory Diagnosis of Human Brucellosis.

Authors:  Pablo Yagupsky; Pilar Morata; Juan D Colmenero
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

5.  The first case of Brucella canis in Sweden: background, case report and recommendations from a northern European perspective.

Authors:  Bodil Ström Holst; Karin Löfqvist; Linda Ernholm; Karin Eld; Maria Cedersmyg; Gunilla Hallgren
Journal:  Acta Vet Scand       Date:  2012-03-27       Impact factor: 1.695

6.  Seroprevalence of Brucella canis antibodies in dogs entering a Minnesota humane society, Minnesota, 2016-2017.

Authors:  Tory V Whitten; Graham Brayshaw; Devi Patnayak; Julio Alvarez; Christina M Larson; Margaret Root Kustritz; Stacy M Holzbauer; Jerry Torrison; Joni M Scheftel
Journal:  Prev Vet Med       Date:  2019-04-29       Impact factor: 2.670

7.  Evaluation of the Efficacy of the Brucella canis RM6/66 ΔvjbR Vaccine Candidate for Protection against B. canis Infection in Mice.

Authors:  Daniel G Garcia-Gonzalez; Omar H Khalaf; Lauren W Stranahan; Sankar P Chaki; Angela M Arenas-Gamboa
Journal:  mSphere       Date:  2020-05-20       Impact factor: 4.389

8.  Primary and memory immune responses against rough Brucella canis are less robust compared to smooth B. abortus and B. melitensis following intratracheal infection in mice.

Authors:  Lauren W Stranahan; Daniel G Garcia-Gonzalez; Martha E Hensel; Angela M Arenas-Gamboa
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

9.  Human infection with M- strain of Brucella canis.

Authors:  Jorge C Wallach; Guillermo H Giambartolomei; Pablo C Baldi; Carlos A Fossati
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.